The content discusses the importance of genetic testing in Parkinson's disease (PD) for precision medicine. It highlights the failure of a clinical trial by Sanofi Genzyme targeting a specific genetic mutation in PD patients but emphasizes the significance of genetic testing for future drug development. The article explores ongoing clinical trials focusing on specific PD-related gene variants and the challenges associated with genetic testing not being a routine part of PD care. It also delves into the PD GENEration project by the Parkinson's Foundation, offering free genetic testing to PD patients and the overwhelming patient interest in learning about their genetic risk factors for PD.
To Another Language
from source content
www.medscape.com
Key Insights Distilled From
by Kelli Whitlo... at www.medscape.com 07-26-2023
https://www.medscape.com/viewarticle/994849Deeper Inquiries